----

----

| [X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934                   |
|--------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                     |   |
|                                                                                                                     | For the quarterly period ended June 30, 2014 |
|                                                                                                                     |   |
| [   ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|                                                                                                                     |
|                                                                                                                     | For the transition period from __________ to __________ |

| 000-53669                                                                          |
|------------------------------------------------------------------------------------|
| Commission File Number                                                             |
|                                                                               |
| EPOXY, INC.                                                                        |
| (Exact name of registrant as specified in its charter)                             |
|                                                                               |   |
| Nevada                                                                             | N/A |
| (State or other jurisdiction of incorporation or organization)                     | (I.R.S. Employer Identification No.) |
|                                                                               |   |
| 500N. Rainbow Blvd. Suite 300, Las Vegas, Nevada                                   | 89107 |
| (Address of principal executive offices)                                           | (Zip Code) |
|                                                                               |
| 702-350-2449                                                                       |
| (Registrant’s  telephone number, including area code)              |
|                                                                               |
| NEOHYDRO TECHNOLOGIES CORP                                                         |
| (Former name, former address and former fiscal year, if changed since last report) |

|   | Yes [X]  No [  ] |
|--------|--------------------------------------|

|   | Yes [  ]  No [ X ] |
|--------|----------------------------------------|

| Large accelerated filer                       | [  ] | Accelerated filer         | [  ] |
|-----------------------------------------------|----------------|---------------------------|-----------|
|                                          |           |                      |      |
| Non-accelerated filer                         | [  ] | Smaller reporting company | [X]       |
| (Do not check if a smaller reporting company) |           |                      |      |

|   | Yes [  ]  No [X ] |
|--------|---------------------------------------|

----

|   | Yes [  ]  No [  ] |
|--------|-------------------------------------------------|

| 169,758,040 shares of common stock outstanding as of August 14, 2014                                                                  |
|---------------------------------------------------------------------------------------------------------------------------------------|
| (Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.) |

----

|     |                                                                                        | Page      |
|----------|---------------------------------------------------------------------------------------------|-----------|
|     | PART I – FINANCIAL INFORMATION                                                        |      |
|     |                                                                                        |      |
| Item 1.  | Financial Statements                                                                        |   4  |
|     |                                                                                        |      |
| Item 2.  | Management’s Discussion and Analysis of Financial Condition and Results of Operations |   5  |
|     |                                                                                        |      |
| Item 3.  | Quantitative and Qualitative Disclosures About Market Risk                                  |   10 |
|     |                                                                                        |      |
| Item 4.  | Controls and Procedures                                                                     |   10 |
|     |                                                                                        |      |
|     | PART II – OTHER INFORMATION                                                           |      |
|     |                                                                                        |      |
| Item 1.  | Legal Proceedings                                                                           |   11 |
|     |                                                                                        |      |
| Item 1A. | Risk Factors                                                                                |   11 |
|     |                                                                                        |      |
| Item 2.  | Unregistered Sales of Equity Securities and Use of Proceeds                                 |   11 |
|     |                                                                                        |      |
| Item 3.  | Defaults Upon Senior Securities                                                             |   11 |
|     |                                                                                        |      |
| Item 4.  | Mine Safety Disclosures                                                                     |   11 |
|     |                                                                                        |      |
| Item 5.  | Other Information                                                                           |   11 |
|     |                                                                                        |      |
| Item 6.  | Exhibits                                                                                    |   12 |
|     |                                                                                        |      |
|     | SIGNATURES                                                                                  |   13 |

----

ITEM 

|                                                                                                      | Page       |
|-----------------------------------------------------------------------------------------------------------|------------|
| Unaudited Consolidated Balance Sheets as of June 30, 2014 and December 31,2013                            | F-1        |
| Unaudited Consolidated Statements of Operations for the three and six months ended June 30, 2014 and 2013 | F-2        |
| Unaudited Consolidated Statement of Cash Flows for the six months ended June 30, 2014 and 2013            | F-3        |
| Notes to the Unaudited Consolidated Financial Statements                                                  | F-4 to F-9 |

----

EPOXY

|                                                                                                                                              |   | June 30,2014 |      |   | December 31,2013 |   |
|---------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------------|-----------|--------|------------------|--------|
|  ASSETS                                                                                                                                      |   |         |      |   |             |   |
| Current                                                                                                                                           |   |         |      |   |             |   |
| Cash                                                                                                                                              |   | $            | 544       |   |             | $      | 30,467 |   |
| Accounts receivable                                                                                                                               |   |         | 1,080     |   |             |   | 2,330 |   |
| Total Current Assets                                                                                                                              |   |         | 1,624     |   |             |   | 32,797 |   |
|                                                                                                                                              |   |         |      |   |             |   |   |   |
| Trademark and Patent, net                                                                                                                         |   |         | 7,695     |   |             |   | 7,695 |   |
|                                                                                                                                              |   |         |      |   |             |   |   |   |
| Total Assets                                                                                                                                      |   | $            | 9,319     |   |             | $      | 40,492 |   |
|                                                                                                                                              |   |         |      |   |             |   |   |   |
| LIABILITIES                                                                                                                                       |   |         |      |   |             |   |   |   |
| Current                                                                                                                                           |   |         |      |   |             |   |   |   |
| Accounts payable and accrued liabilities                                                                                                          |   |         | 88,117    |   |             |   | 64,401 |   |
| Loan payable                                                                                                                                      |   |         | 63,085    |   |             |   | 63,573 |   |
| Derivative liabilities                                                                                                                            |   |         | 51,708    |   |             |   | 23,790 |   |
| Total Current Liabilities                                                                                                                         |   |         | 202,910   |   |             |   | 151,764 |   |
|                                                                                                                                              |   |         |      |   |             |   |   |   |
| Convertible notes, net of unamortized discount                                                                                                    |   |         | 33,863    |   |             |   | 19,190 |   |
|                                                                                                                                              |   |         |      |   |             |   |   |   |
| Total Liabilities                                                                                                                                 |   |         | 236,773   |   |             |   | 170,954 |   |
|                                                                                                                                              |   |         |      |   |             |   |   |   |
| STOCKHOLDERS’ DEFICIT                                                                                                                       |   |         |      |   |             |   |   |   |
| Preferred Stock, $0.00001 par value;                                                                                                              |   |         |      |   |             |   |   |   |
| authorized: 35,000,000 Series A Preferred shares, 25,080,985 issued and outstanding as of June 30, 2014 and December 31, 2013                     |   |         | 251       |   |             |   | 251 |   |
| authorized: 15,000,000 Series B Preferred shares, no shares issued and outstanding as of June 30, 2014 and December 31, 2013                      |   |         | -         |   |             |   | - |   |
| Common Stock, $0.00001 par value;                                                                                                                 |   |         |      |   |             |   |   |   |
| authorized: 480,000,000 shares, 169,758,040 and 168,824,707 shares issued and outstanding as of June 30, 2014 and December 31, 2013, respectively |   |         | 1,697     |   |             |   | 1,688 |   |
| Additional Paid-in Capital                                                                                                                        |   |         | 172,475   |   |             |   | 152,689 |   |
| Accumulated deficit                                                                                                                               |   |         | (401,877) |   |             |   | (285,090) |   |
| Total Stockholders’ Deficit                                                                                                                 |   |         | (227,454) |   |             |   | (130,462) |   |
| Total Liabilities and Stockholders’ Deficit                                                                                                 |   | $            | 9,319     |   |             | $      | 40,492 |   |

----

EPOXY

|                                                          |   | Three month ended |        |   | Six months ended |   |
|---------------------------------------------------------------|--------|-------------------|-------------|--------|------------------|--------|
|                                                          |   | June 30,          |        |   | June 30,         |   |
|                                                          |   | 2014              |        |   | 2013             |   |   | 2014 |   |   | 2013 |   |
|                                                          |   |              |        |   |             |   |   |   |   |   |   |   |
| Revenue                                                       |   | $                 | 3,349       |   |             | $      | 2,916 |   |   | $ | 7,734 |   |   | $ | 5,290 |   |
|                                                          |   |              |        |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Operating Expenses                                            |   |              |        |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Professional fees                                             |   |              | 19,128      |   |             |   | 522 |   |   |   | 27,964 |   |   |   | 828 |   |
| Software development expenses                                 |   |              | 6,461       |   |             |   | 6,204 |   |   |   | 14,176 |   |   |   | 28,738 |   |
| Consulting fee                                                |   |              | 14,973      |   |             |   | 6,058 |   |   |   | 22,955 |   |   |   | 10,448 |   |
| General and administrative expenses                           |   |              | 11,131      |   |             |   | 19,221 |   |   |   | 18,592 |   |   |   | 38,316 |   |
| Total operating expenses                                      |   |              | 51,693      |   |             |   | 32,005 |   |   |   | 83,687 |   |   |   | 78,330 |   |
| Loss from operations                                          |   |              | (48,344     | )      |             |   | (29,089 | ) |   |   | (75,953 | ) |   |   | (73,040 | ) |
|                                                          |   |              |        |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Other Income (Expenses):                                      |   |              |        |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Loss on change in fair value of derivative liabilities        |   |              | (19,701     | )      |             |   | - |   |   |   | (16,727 | ) |   |   | - |   |
| Interest expenses                                             |   |              | (4,735      | )      |             |   | - |   |   |   | (9,435 | ) |   |   | - |   |
| Accretion of discount on convertible notes                    |   |              | (7,940      | )      |             |   | - |   |   |   | (14,672 | ) |   |   | - |   |
| Total other expenses                                          |   |              | (32,376     | )      |             |   | - |   |   |   | (40,834 | ) |   |   | - |   |
|                                                          |   |              |        |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Net loss                                                      |   | $                 | (80,720     | )      |             |   | (29,089 | ) |   | $ | (116,787 | ) |   | $ | (73,040 | ) |
|                                                          |   |              |        |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Net loss per share – basic and diluted                  |   | $                 | (0.00       | )      |             |   | (0.00 | ) |   | $ | (0.00 | ) |   | $ | (0.00 | ) |
|                                                          |   |              |        |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Weighted average shares outstanding – basic and diluted |   |              | 169,450,348 |   |             |   | 24,514,319 |   |   |   | 169,139,256 |   |   |   | 24,514,319 |   |

----

EPOXY, INC.

|                                                              |   | Six Month ended |      |
|-------------------------------------------------------------------|--------|-----------------|-----------|
|                                                              |   | June 30,        |      |
|                                                              |   | 2014            |      |   | 2013 |   |
| Cash flows from Operating Activities                              |   |            |      |   |   |   |
| Net loss                                                          |   | $               | (116,787) |   |   | $ | (73,040) |   |
| Adjustments to reconcile net loss to net cash used in operations: |   |            |      |   |   |   |   |   |
| Amortization of trademark and patent                              |   |            | -         |   |   |   | 689 |   |
| Loss on change in fair value of derivative liabilities            |   |            | 16,727    |   |   |   |   - |   |
| Accretion of discounts on convertible notes                       |   |            | 14,672    |   |   |   | - |   |
| Imputed interest                                                  |   |            | 2,986     |   |   |   | - |   |
| Foreign exchange in loan payable                                  |   |            | (488)     |   |   |   |   - |   |
|                                                              |   |            |      |   |   |   |   |   |
| Changes in operating assets and liabilities:                      |   |            |      |   |   |   |   |   |
| Accounts receivables                                              |   |            | 1,250     |   |   |   | (1,250) |   |
| Accrued expenses                                                  |   |            | 16,583    |   |   |   | - |   |
| Accounts payable                                                  |   |            | 7,134     |   |   |   | (7,572) |   |
| Net cash used in operating activities                             |   |            | (57,923)  |   |   |   | (81,173) |   |
|                                                              |   |            |      |   |   |   |   |   |
|                                                              |   |            |      |   |   |   |   |   |
| Cash flows from Financing Activities                              |   |            |      |   |   |   |   |   |
| Proceeds from sale of common stock                                |   |            | 28,000    |   |   |   |   - |   |
| Proceeds from loan payable                                        |   |            | -         |   |   |   | 83,198 |   |
| Net cash provided by financing activities                         |   |            | 28,000    |   |   |   | 83,198 |   |
|                                                              |   |            |      |   |   |   |   |   |
| Increase (decrease) in cash during the period                     |   |            | (29,923)  |   |   |   | 2,025 |   |
| Cash, beginning of period                                         |   |            | 30,467    |   |   |   | 492 |   |
| Cash, end of period                                               |   | $               | 544       |   |   | $ | 2,517 |   |
|                                                              |   |            |      |   |   |   |   |   |
| Supplemental disclosure of cash flow information:                 |   |            |      |   |   |   |   |   |
| Cash paid for:                                                    |   |            |      |   |   |   |   |   |
|     Interest                                  |   | $               | 2,986     |   |   | $ | - |   |
|     Income taxes                              |   | $               | -         |   |   | $ | - |   |
|                                                              |   |            |      |   |   |   |   |   |
| Non-Cash Transactions                                             |   |            |      |   |   |   |   |   |
| Shares and warrants reclassified as derivative liability          |   | $               | 11,191    |   |   | $ |   | - |

----

EPOXY

----

|                                        |   | December 31, 2013(As Adjusted) |     |   | December 31, 2013(Original) |   |
|---------------------------------------------|--------|--------------------------------|----------|--------|-----------------------------|--------|
| Consolidated Balance Sheets:                |   |                           |     |   |                        |   |
| Derivative liabilities                      |   | $                              | 23,790   |   |                        | $      | 37,614 |   |
| Total Liabilities                           |   | $                              | 170,954  |   |                        | $      | 184,778 |   |
| Additional paid in capital                  |   | $                              | 152,689  |   |                        | $      | 138,865 |   |
| Total stockholders' deficit                 |   | $                              | (130,462 | )      |                        | $      | (144,286 | ) |
| Total liabilities and stockholders' deficit |   | $                              | 40,492   |   |                        | $      | 40,492 |   |

|                     |   | Fair value measurementson a recurring basis |   |
|--------------------------|--------|---------------------------------------------|--------|
|                     |   | Level 1                                     |   |   | Level 2 |   |   | Level 3 |   |
| As of June 30, 2014:     |   |                                        |   |   |   |   |   |   |   |   |   |   |
| Liabilities              |   |                                        |   |   |   |   |   |   |   |   |   |   |
| Embedded derivative      |   | $                                           | -      |   |   | $ | - |   |   | $ | 51,708 |   |
|                     |   |                                        |   |   |   |   |   |   |   |   |   |   |
| As of December 31, 2013: |   |                                        |   |   |   |   |   |   |   |   |   |   |
| Liabilities              |   |                                        |   |   |   |   |   |   |   |   |   |   |
| Embedded derivative      |   | $                                           | -      |   |   | $ | - |   |   | $ | 23,790 |   |

----

| a) | On November 27, 2012, the Company entered into a convertible loan agreement. The Company received $25,000 which bears interest at 10% per annum and is due on November 27, 2015. Interest shall accrue from the advancement date and shall be payable quarterly. Any portion of the loan and unpaid interest are convertible at any time at the option of the lender into shares of common stock of the Company at a conversion price of $0.0005 per share. The Company recognized the intrinsic value of the embedded beneficial conversion feature of $25,000 as additional paid-in capital and reduced the carrying value of the convertible debenture to $nil. The carrying value will be accreted over the term of the convertible debenture up to its face value of $25,000. At June 30, 2014, the carrying values of the convertible debenture and accrued convertible interest thereon were $7,057 and $3,973, respectively. |
|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| b) | On November 27, 2012, the Company entered into a convertible loan agreement. The Company received $25,000 which bears interest at 10% per annum and is due on November 27, 2015. Interest shall accrue from the advancement date and shall be payable quarterly. Any portion of the loan and unpaid interest are convertible at any time at the option of the lender into shares of common stock of the Company at a conversion price of $0.0005 per share. The Company recognized the intrinsic value of the embedded beneficial conversion feature of $25,000 as additional paid-in capital and reduced the carrying value of the convertible debenture to $nil. The carrying value will be accreted over the term of the convertible debenture up to its face value of $25,000. As at June 30, 2014, the carrying values of the convertible debenture and accrued convertible interest thereon were $7,057 and $3,973, respectively. |
|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| c) | On November 27, 2012, the Company entered into a convertible loan agreement. The Company received $40,000 which bears interest at 10% per annum and is due on November 27, 2015. Interest shall accrue from the advancement date and shall be payable quarterly. Any portion of the loan and unpaid interest are convertible at any time at the option of the lender into shares of common stock of the Company at a conversion price of $0.0005 per share. The Company recognized the intrinsic value of the embedded beneficial conversion feature of $40,000 as additional paid-in capital and reduced the carrying value of the convertible debenture to $nil. The carrying value will be accreted over the term of the convertible debenture up to its face value of $40,000. As at June 30, 2014, the carrying values of the convertible debenture and accrued convertible interest thereon were $11,292 and $5,337, respectively. |
|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| d) | On November 27, 2012, the Company entered into a convertible loan agreement. The Company received $35,000 which bears interest at 10% per annum and is due on November 27, 2015. Interest shall accrue from the advancement date and shall be payable quarterly. Any portion of the loan and unpaid interest are convertible at any time at the option of the lender into shares of common stock of the Company at a conversion price of $0.0005 per share. The Company recognized the intrinsic value of the embedded beneficial conversion feature of $35,000 as additional paid-in capital and reduced the carrying value of the convertible debenture to $nil. The carrying value will be accreted over the term of the convertible debenture up to its face value of $35,000. As at June 30, 2014, the carrying values of the convertible debenture and accrued convertible interest thereon were $8,457 and $5,562, respectively. |
|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|                              |   | Warrants |    |   | Weighted Average Exercise Price |   |
|-----------------------------------|--------|----------|---------|--------|---------------------------------|--------|
| Outstanding - December 31, 2013   |   |     | 856,667 |   |                            |   | 0.12 |   |
| Granted                           |   |     | 93,333  |   |                            |   | 0.30 |   |
| Forfeited/Canceled                |   |     | -       |   |                            |   | - |   |
| Exercised                         |   |     | -       |   |                            |   | - |   |
| Outstanding – June 30, 2014 |   |     | 950,000 |   |                            |   | 0.14 |   |
| Exercisable – June 30, 2014 |   |     | 950,000 |   |                            |   | 0.14 |   |

|   | 169,758,040 |   | Common Stock Issued and Outstanding                                                         |
|--------|-------------|--------|---------------------------------------------------------------------------------------------|
|   |        |   |                                                                                        |
|   | 950,000     |   | Common Shares exercised from warrants (950,000 warrants outstanding)                        |
|   | 250,000,000 |   | Common Shares convertible from convertible notes ($125,000 converted at $0.0005 per share ) |
|   | 62,702,463  |   | Common Shares convertible from Preferred Series A (25,080,985 shares outstanding)           |
|   | 1,333,333   |   | Common Shares convertible from Preferred Series A warrants (533,333 warrants outstanding)   |
|   | 484,743,836 |   | Total Common Shares Outstanding and Accounted For/Reserved                                  |

----

|                                                 |   | Exceed number of authorized shares |      |   | Derivate Liabilities |   |
|------------------------------------------------------|--------|------------------------------------|-----------|--------|----------------------|--------|
|                                                 |   |                               |      |   |                 |   |
| Balance, December 31, 2013                           |   |                               | 3,717,169 |   |                 | $      | 23,790 |   |
| Add:  Common shares issued                 |   |                               | 933,334   |   |                 |   | 10,174 |   |
|  Common shares for exercise underlying warrants |   |                               | 93,333    |   |                 |   | 1,017 |   |
| Change in fair value of derivative liabilities       |   |                               | -         |   |                 |   | 16,727 |   |
| Balance: June 30, 2014                               |   |                               | 4,743,836 |   |                 | $      | 51,708 |   |
|                                                 |   |                               |      |   |                 |   |   |   |

----

|   | a. | 10% of the amount for any equity or hybrid equity capital raised up to $2,000,000  |
|--------|----|-----------------------------------------------------------------------------------------|

|   | b. | 8% of the amount for any equity or hybrid equity capital raised up to $5,000,000  |
|--------|----|----------------------------------------------------------------------------------------|

|   | c. | 6% of the amount for any equity or hybrid equity capital raised over $5,000,000 |
|--------|----|---------------------------------------------------------------------------------|

----

ITEM 

----

----

|                                                   |   | Three months ended |    |
|--------------------------------------------------------|--------|--------------------|---------|
|                                                   |   | June 30,           |    |
|                                                   |   | 2014               |    |   | 2013 |   |
|                                                   |   |               |    |   |   |   |
| Revenue                                                |   | $                  | 3,349   |   |   | $ | 2,916 |   |
|                                                   |   |               |    |   |   |   |   |   |
| Operating Expenses                                     |   |               |    |   |   |   |   |   |
| Professional fees                                      |   |               | 19,128  |   |   |   | 522 |   |
| Software development expenses                          |   |               | 6,461   |   |   |   | 6,204 |   |
| Consulting fee                                         |   |               | 14,973  |   |   |   | 6,058 |   |
| General and administrative expenses                    |   |               | 11,131  |   |   |   | 19,221 |   |
| Total operating expenses                               |   |               | 51,693  |   |   |   | 32,005 |   |
| Loss from operations                                   |   |               | (48,344 | ) |   |   | (29,089 | ) |
|                                                   |   |               |    |   |   |   |   |   |
| Other Income (Expenses):                               |   |               |    |   |   |   |   |   |
| Loss on change in fair value of derivative liabilities |   |               | (19,701 | ) |   |   | - |   |
| Interest expenses                                      |   |               | (4,735  | ) |   |   | - |   |
| Accretion of discount on convertible notes             |   |               | (7,940  | ) |   |   | - |   |
| Total other expenses                                   |   |               | (32,376 | ) |   |   | - |   |
|                                                   |   |               |    |   |   |   |   |   |
| Net loss                                               |   | $                  | (80,720 | ) |   |   | (29,089 | ) |

|                                                   |   | Six months ended |     |
|--------------------------------------------------------|--------|------------------|----------|
|                                                   |   | June 30,         |     |
|                                                   |   | 2014             |     |   | 2013 |   |
|                                                   |   |             |     |   |   |   |
| Revenue                                                |   | $                | 7,734    |   |   | $ | 5,290 |   |
|                                                   |   |             |     |   |   |   |   |   |
| Operating Expenses                                     |   |             |     |   |   |   |   |   |
| Professional fees                                      |   |             | 27,964   |   |   |   | 828 |   |
| Software development expenses                          |   |             | 14,176   |   |   |   | 28,738 |   |
| Consulting fee                                         |   |             | 22,955   |   |   |   | 10,448 |   |
| General and administrative expenses                    |   |             | 18,592   |   |   |   | 38,316 |   |
| Total operating expenses                               |   |             | 83,687   |   |   |   | 78,330 |   |
| Loss from operations                                   |   |             | (75,953  | ) |   |   | (73,040 | ) |
|                                                   |   |             |     |   |   |   |   |   |
| Other Income (Expenses):                               |   |             |     |   |   |   |   |   |
| Loss on change in fair value of derivative liabilities |   |             | (16,727  | ) |   |   | - |   |
| Interest expenses                                      |   |             | (9,435   | ) |   |   | - |   |
| Accretion of discount on convertible notes             |   |             | (14,672  | ) |   |   | - |   |
| Total other expenses                                   |   |             | (40,834  | ) |   |   | - |   |
|                                                   |   |             |     |   |   |   |   |   |
| Net loss                                               |   | $                | (116,787 | ) |   | $ | (73,040 | ) |

----

|                      |   | At June 30, 2014 |     |   | At December 31, 2013 |   |
|---------------------------|--------|------------------|----------|--------|----------------------|--------|
| Current Assets            |   | $                | 1,624    |   |                 | $      | 32,797 |   |
| Current Liabilities       |   | $                | 202,910  |   |                 | $      | 151,764 |   |
| Working Capital (Deficit) |   | $                | (201,286 | )      |                 | $      | (118,967 | ) |

| Cash Flows                                    |   |                    |    |   |               |
|-----------------------------------------------|--------|-------------------------|---------|--------|--------------------|
|                                          |   | Six Month Periods Ended |    |
|                                          |   | June 30, 2014      |    |   | June 30, 2013 |   |
| Net cash used in operating activities         |   | $                       | (57,923 | )      |               | $ | (81,173 | ) |
| Net cash provided by financing activities     |   | $                       | 28,000  |   |               | $ | 83,198 |   |
| Net increase (decrease) in cash during period |   | $                       | (29,923 | )      |               | $ | 2,025 |   |

----

----

ITEM 

----

PART II – OTHER INFORMATION

| a.   | 10% of the amount for any equity or hybrid equity capital raised up to $2,000,000  |
|----------------|-----------------------------------------------------------------------------------------|

| b.   | 8% of the amount for any equity or hybrid equity capital raised up to $5,000,000  |
|----------------|----------------------------------------------------------------------------------------|

| c.   | 6% of the amount for any equity or hybrid equity capital raised over $5,000,000 |
|----------------|---------------------------------------------------------------------------------|

----

ITEM 

|    |                                                                                                          |           | Incorporated by reference |    |
|---------|---------------------------------------------------------------------------------------------------------------|----------------|---------------------------|---------|
| Exhibit | Exhibit Description                                                                                           | Filed herewith | Form                      | Exhibit | Filing Date |   |
| 3.1     | Articles of Incorporation                                                                                     |           | S-1                       | 3.1     | 03/18/08 |   |
| 3.2     | By-laws as currently in effect                                                                                |           | S-1                       | 3.2     | 03/18/08 |   |
| 10.1    | Agency Agreement with Carter, Terry & Company executed August 8, 2014                                     | X              |                      |    |   |   |
| 31.1    | Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act                | X              |                      |    |   |   |
| 31.2    | Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act                | X              |                      |    |   |   |
| 32.1    | Certification of Principal Executive and Financial Officer, pursuant to Section 906 of the Sarbanes-Oxley Act |  X   |                      |    |   |   |

----

SIGNATURES

|                  | EPOXY, INC.(FORMERLY NEOHYRDO TECHNOLOGIES CORP.) |                                                                                                                    |
|-----------------------|---------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------|
|                  |                                              |                                                                                                                    |   |
| Date: August 14, 2014 | By:                                               | /s/ David Gasparine                                                                                                     |   |
|                  | Name:                                             | David Gasparine                                                                                                         |   |
|                  | Title:                                            | Chief Executive Officer (Principal Executive Officer), Treasurer, (Principal Financial Officer) Secretary, and Director |   |
|                  |                                              |                                                                                                                    |   |

----